The Life and Death of Mammograms in Patients 75 Years and Older—To Screen or Not to Screen?
Mené aux Etats-Unis auprès de 546 femmes âgées de 75 ans ou plus (âge moyen : 79,8 ans ; durée de suivi : 18 mois), cet essai évalue l'effet d'une intervention, destinée à informer sur les bénéfices et les risques liés à une mammographie, sur la décision d'arrêter les examens de dépistage du cancer du sein
Discussions about stopping breast cancer screening in asymptomatic women 75 years and older are challenging for both physicians and women. Because randomized clinical trials that evaluated screening mammography excluded women in this age group, there are no empirical trial data that address whether screening women 75 years and older is beneficial. In this issue of JAMA Internal Medicine, Schonberg et al evaluated a decision aid to help older women decide whether to continue screening mammography. Most of the information conveyed in the decision aid studied by Schonberg and colleagues was based on evidence-based extrapolations from simulation modeling and was clearly presented. Women who were randomized to receive the decision aid were more knowledgeable about screening and more likely to discuss mammography with their primary care clinician. Almost all said that they would recommend it to others.
JAMA Internal Medicine , commentaire, 2019